急性肾损伤合并脓毒症患者肾脏替代治疗的时机
该多中心随机对照试验纳入早期脓毒性休克且达到RIFLE分类衰竭期但无急性肾损伤相关危及生命并发症的患者,随机分为早期策略(记录到衰竭期急性肾损伤后12小时内启动肾脏替代治疗)或延迟策略(若48小时后肾功能未恢复则启动)。试验在第二次计划中期分析后因无效而提前终止,共488例患者随机分组。90天随访数据可用的477例中,早期策略组死亡138/239例(58%),延迟策略组死亡128/238例(54%),组间无显著差异(P=0.38)。延迟策略组中38%(93例)未接受肾脏替代治疗,17%(41例)满足了紧急肾脏替代治疗的标准。
要点
- 在早期脓毒性休克合并严重急性肾损伤(RIFLE衰竭期)且无急性肾损伤相关危及生命并发症的患者中,早期(12小时内)与延迟(48小时后)启动肾脏替代治疗的90天死亡率无显著差异(58% vs 54%,P=0.38)。
- 延迟策略组中38%(93例)未接受肾脏替代治疗,提示部分患者可避免该治疗。
- 延迟策略组中17%(41例)满足了紧急肾脏替代治疗的标准。
- 试验因无效在第二次计划中期分析后提前终止,共随机488例患者。
- RIFLE衰竭期的定义为:血清肌酐为基线水平的3倍(或≥4 mg/dl且快速升高≥0.5 mg/dl),或尿量<0.3 ml/kg/h持续24小时以上,或无尿至少12小时。
适用人群与场景
- 早期脓毒性休克合并严重急性肾损伤(RIFLE分类衰竭期)且无急性肾损伤相关危及生命并发症的患者。
诊断标准与关键阈值
- RIFLE分类系统衰竭期:血清肌酐为基线水平的3倍(或≥4 mg/dl且快速升高≥0.5 mg/dl),或尿量<0.3 ml/kg/h持续24小时以上,或无尿至少12小时。
处置流程与药物剂量
- 早期策略:记录到衰竭期急性肾损伤后12小时内启动肾脏替代治疗。
- 延迟策略:若48小时后肾功能未恢复则启动肾脏替代治疗。
研究设计与关键结果
- 多中心随机对照试验,共488例患者随机分组,试验因无效在第二次计划中期分析后提前终止。
- 90天随访数据可用的477例中,早期策略组死亡138/239例(58%),延迟策略组死亡128/238例(54%),无显著差异(P=0.38)。
- 延迟策略组中38%(93例)未接受肾脏替代治疗。
- 延迟策略组中17%(41例)满足了紧急肾脏替代治疗的标准。
证据类型、等级与局限
- 证据类型:多中心随机对照试验(IDEAL-ICU,NCT01682590),法国卫生部资助。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于早期脓毒性休克合并严重急性肾损伤(RIFLE衰竭期)且无急性肾损伤相关危及生命并发症的患者,早期(12小时内)启动肾脏替代治疗与延迟(48小时后)启动相比,90天死亡率无显著差异。
- 延迟策略可使部分患者(38%)避免肾脏替代治疗,但需注意17%的患者在延迟期间满足了紧急肾脏替代治疗的标准。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute kidney injury is the most frequent complication in patients with septic shock and is an independent risk factor for death. Although renal-replacement therapy is the standard of care for severe acute kidney injury, the ideal time for initiation remains controversial.
METHODS: In a multicenter, randomized, controlled trial, we assigned patients with early-stage septic shock who had severe acute kidney injury at the failure stage of the risk, injury, failure, loss, and end-stage kidney disease (RIFLE) classification system but without life-threatening complications related to acute kidney injury to receive renal-replacement therapy either within 12 hours after documentation of failure-stage acute kidney injury (early strategy) or after a delay of 48 hours if renal recovery had not occurred (delayed strategy). The failure stage of the RIFLE classification system is characterized by a serum creatinine level 3 times the baseline level (or ≥4 mg per deciliter with a rapid increase of ≥0.5 mg per deciliter), urine output less than 0.3 ml per kilogram of body weight per hour for 24 hours or longer, or anuria for at least 12 hours. The primary outcome was death at 90 days.
RESULTS: The trial was stopped early for futility after the second planned interim analysis. A total of 488 patients underwent randomization; there were no significant between-group differences in the characteristics at baseline. Among the 477 patients for whom follow-up data at 90 days were available, 58% of the patients in the early-strategy group (138 of 239 patients) and 54% in the delayed-strategy group (128 of 238 patients) had died (P=0.38). In the delayed-strategy group, 38% (93 patients) did not receive renal-replacement therapy. Criteria for emergency renal-replacement therapy were met in 17% of the patients in the delayed-strategy group (41 patients).
CONCLUSIONS: Among patients with septic shock who had severe acute kidney injury, there was no significant difference in overall mortality at 90 days between patients who were assigned to an early strategy for the initiation of renal-replacement therapy and those who were assigned to a delayed strategy. (Funded by the French Ministry of Health; IDEAL-ICU ClinicalTrials.gov number, NCT01682590 .).
参考来源
- Barbar SD, Clere-Jehl R, Bourredjem A, et al. Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis. N Engl J Med. 2018. PMID: 30304656. doi:10.1056/NEJMoa1803213
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。